25 Feb 2009 15:00
| Press Release | 25 February 2009 |
e-Therapeutics plc
("e-therapeutics" or the "Company")
Notice of General Meeting
Further to the announcement made earlier today, the Company confirms that a circular has now been dispatched to shareholders to convene a general meeting ("GM") of the Company at 10.30 am on 16 March 2009 at the Company's registered office, Holland Park, Holland Drive, Newcastle upon Tyne, NE2 4LZ.
A copy of the circular is available from the Company's website www.etherapeutics.co.uk.
At the General Meeting the following resolutions will be proposed:
an ordinary resolution to increase the authorised share capital of the Company from £83,766.47 to £100,218.15 by the creation of an additional 16,451,684 new Ordinary Shares;
an ordinary resolution to authorise directors to allot relevant securities pursuant to section 80 of the Companies Act 1985 up to aggregate maximum nominal amount of £44,508.05; and
a special resolution to disapply the pre-emption provision contained in section 89(1) of the Companies Act 1985 in respect of the allotment of equity securities up to an aggregate nominal amount of £21,824.01 in connection with the authority referred to in (2) above.
For further information:
| John Cordiner, e-Therapeutics plc | +44 (0) 191 233 1317 |
| Katy Mitchell/David Youngman WH Ireland Limited | +44 (0) 113 394 6628 |
Media enquiries:
| Abchurch Communications | www.abchurch-group.com +44 (0) 207 398 7700 |
| Heather Salmond heather.salmond@abchurch-group.com | +44 (0) 207 398 7704 |
| Stephanie Cuthbert stephanie.cuthbert@abchurch-group.com | +44 (0) 207 398 7718 |
| Simone Alves simone.alves@abchurch-group.com | +44 (0) 207 398 7728 |